Treatment of Acute Retinal Necrosis Syndrome with Oral Antiviral Medications

Ophthalmology

Volumn 114, Issue 2, 2007, Pages 307-312

  Aizman, Alexander ^a   Johnson, Mark W ^a   Elner, Susan G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; FOSCARNET; PREDNISONE; VALACICLOVIR;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; KIRISAWA UVEITIS; MALE; PRIORITY JOURNAL; RETINA DETACHMENT; RETINITIS; RETROSPECTIVE STUDY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VITRECTOMY;

2-AMINOPURINE; ACYCLOVIR; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; EYE INFECTIONS, VIRAL; FEMALE; FOLLOW-UP STUDIES; HERPES SIMPLEX; HERPES ZOSTER OPHTHALMICUS; HUMANS; MALE; PILOT PROJECTS; RETINAL NECROSIS SYNDROME, ACUTE; RETROSPECTIVE STUDIES; VALINE; VISUAL ACUITY;

EID: 33846488357     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.06.058     Document Type: Article

References (32)

1. Urayama A., Yamada N., Sasaki T., et al. Unilateral acute uveitis with periarteritis and detachment [in Japanese]. Rinsho Ganka 25 (1971) 607-619
2. Culbertson W.W., Blumenkranz M.S., Haines H., et al. The acute retinal necrosis syndrome. Part 2. Histopathology and etiology. Ophthalmology 89 (1982) 1317-1325
3. Culbertson W.W., Blumenkranz M.S., Pepose J.S., et al. Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology 93 (1986) 559-569
4. Holland G.N., and Executive Committee of the American Uveitis Society. Standard diagnostic criteria for the acute retinal necrosis syndrome. Am J Ophthalmol 117 (1994) 663-667
5. Nussenblatt R.B., and Whitcup S.M. Uveitis: Fundamentals and Clinical Practice. 3rd ed. (2004), Mosby, Philadelphia 201-202
6. Figueroa M.S., Garabito I., Gutierrez C., and Fortun J. Famciclovir for the treatment of acute retinal necrosis (ARN) syndrome. Am J Ophthalmol 123 (1997) 255-257
7. Aslanides I.M., De Souza S., Wong D.T., et al. Oral valacyclovir in the treatment of acute retinal necrosis syndrome. Retina 22 (2002) 352-354
8. Grant D.M., Mauskopf J.A., Bell L., and Austin R. Comparison of valacyclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model. Pharmacotherapy 17 (1997) 333-341
9. Holland G.N., Buhles Jr. W.C., Mastre B., et al. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome. Arch Ophthalmol 107 (1989) 1759-1766
10. Holland G.N., Cornell P.J., Park M.S., et al. An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4. Am J Ophthalmol 108 (1989) 370-374
11. Fisher J.P., Lewis M.L., Blumenkranz M.S., et al. The acute retinal necrosis syndrome. Part 1: clinical manifestations. Ophthalmology 89 (1982) 1309-1316
12. Duker J.S., and Blumenkranz M.S. Diagnosis and management of the acute retinal necrosis (ARN) syndrome. Surv Ophthalmol 35 (1991) 327-343
13. Blumenkranz M.S., Culbertson W.W., Clarkson J.G., and Dix R. Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology 93 (1986) 296-300
14. Morse L.S., and Mizoguchi M. Diagnosis and management of viral retinitis in the acute retinal necrosis syndrome. Semin Ophthalmol 10 (1995) 28-41
15. Palay D.A., Sternberg Jr. P., Davis J., et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol 112 (1991) 250-255
16. Keatings M.R. Antiviral agents. Mayo Clin Proc 67 (1992) 160-178
17. Hayden F.G. Antimicrobial agents. In: Hardman J.G., Limbird L.E., Molinoff P.B., et al. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. (1996), McGraw-Hill, New York 1196-1202
18. Guex-Crosier Y., and Meylan P.R. High dosage of oral valaciclovir as an alternative treatment of varicella zoster acute retinal necrosis syndrome [letter]. Eye 20 (2006) 247
19. Weller S., Blum M.R., Doucette M., et al. Pharmacokinetics of the acyclovir prodrug, valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 54 (1993) 595-605
20. Hoglund M., Ljungman P., and Weller S. Comparable acyclovir exposures produced by oral valaciclovir and intravenous acyclovir in immunocompromised cancer patients. J Antimicrob Chemother 47 (2001) 855-861
21. Soul-Lawton J., Seaber E., On N., et al. Absolute bioavailability and metabolic disposition of valaciclovir, the l-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 39 (1995) 2759-2764
22. Beutner K.R., Friedman D.J., Forszpaniak C., et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39 (1995) 1546-1553
23. Lycke J., Malmestrom C., and Stahle L. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob Agents Chemother 47 (2003) 2438-2441
24. Vere Hodge R.A. Famciclovir and penciclovir: the mode of action of famciclovir including its conversion to penciclovir. Antivir Chem Chemother 4 (1993) 67-84
25. Acosta E.P., and Fletcher C.V. Valacyclovir. Ann Pharmacother 31 (1997) 185-191
26. Rolston K.V., Manzullo E., Elting L., et al. Ambulatory management of varicella-zoster virus infection in immunocompromised cancer patients. Support Care Cancer 6 (1998) 57-62
27. Silverstein B., Conrad D., Margolis T., and Wong I.G. Cytomegalovirus-associated acute retinal necrosis syndrome. Am J Ophthalmol 123 (1997) 257-258
28. Martin D.F., Sierra-Madero J., Walmsley S., et al. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 346 (2002) 1119-1126
29. Savant V., Saeed T., Denniston A., and Murray P.I. Oral valganciclovir treatment of varicella zoster virus acute retinal necrosis [letter]. Eye 18 (2004) 544-545
30. Johnson M.W., Greven C.M., Jaffe G.J., et al. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 104 (1997) 48-57
31. Moshfeghi D.M., Dodds E.M., Couto C.A., et al. Diagnostic approaches to severe atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 111 (2004) 716-725
32. Hanley J.A., and Lippman-Hand A. If nothing goes wrong, is everything all right?. Interpreting zero numerators. JAMA 249 (1983) 1743-1745